Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)

Key facts

Sponsor

University Hospital Heidelberg

Intervention

Duration of Supine Positioning(procedure)

Enrollment

102 enrolled

Eligibility

All sexes

Timeline

2025 – 2027

Study locations (1)

• Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNANCT07217249
  Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
  Case Western Reserve University
• RECRUITINGPHASE2NCT07024693
  DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
  Design Therapeutics, Inc.
• RECRUITINGNANCT06844123
  Microsurgical Robot-assisted Corneal Transplant
  CHU de Reims
• RECRUITINGNANCT06425666
  Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy
  University of Cologne
• RECRUITINGNCT06966167
  Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
  Eye & ENT Hospital of Fudan University
• RECRUITINGNCT06859411
  Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study
  Centre Hospitalier Régional Metz-Thionville
• RECRUITINGPHASE3NCT05275972
  Descemet Endothelial Thickness Comparison Trial II
  Stanford University
• RECRUITINGPHASE2NCT04440280
  Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
  Massachusetts Eye and Ear Infirmary

See all trials for Corneal dystrophy →